Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Metadata
Title
Cardiac Toxicity of High-Dose Cyclophosphamide in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation
Authors
Samo Zver
Vesna Zadnik
Matjaz Bunc
Polona Rogel
Peter Cernelc
Mirta Kozelj
Publication date
01-06-2007
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 5/2007
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.E0620

Other articles of this Issue 5/2007

International Journal of Hematology 5/2007 Go to the issue

OriginalPaper

Interphase Fluorescence In Situ Hybridization Detection of Cytogenetic Abnormalities in B-Cell Chronic Lymphocytic Leukemia

Case report

Splenic Infarction after Epstein-Barr Virus Infection in a Patient with Hereditary Spherocytosis

Letter to the editor

Eosinophils Derived from Acute Promyelocytic Leukemia Cells after Arsenic Trioxide Treatment

OriginalPaper

Factor VIII-Mediated Global Hemostasis in the Absence of von Willebrand Factor

Case report

Primary Gastric Hodgkin’s Lymphoma Expressing a B-Cell Profile Including Oct-2 and Bob-1 Proteins

OriginalPaper

Novel Method for Efficient Production of Multipotential Hematopoietic Progenitors from Human Embryonic Stem Cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits